Pharma news

Reset all filters
Geography
Company
Refine search
Shire suffers Lialda patent defeat at Federal Circuit
Americas
The US Court of Appeals for the Federal Circuit has affirmed a ruling of a district court which favoured Cadila Healthcare and Zydus in a patent dispute against Shire.   10 May 2017
Sanofi seeks to prevent Praluent injunction
Americas
Sanofi and Regeneron have filed the latest round of their appeal to the US Court of Appeals for the Federal Circuit in a bid to stop an injunction against Praluent.   9 May 2017
Generic companies ask district court to dismiss Takeda competition claims
Americas
Four generic companies have pushed a district court to dismiss competition allegations against them, stating that the latest amendments made by American Sales Company in a class action complaint are “purely cosmetic” and add no new factual allegations.   9 May 2017
Americas
A judge at the US District Court for the Southern District of Indiana has handed down a final judgment in a patent dispute between Eli Lilly and Sun Pharmaceutical favouring Eli Lilly.   3 May 2017
Americas
The number of Abbreviated New Drug Application disputes filed in 2016 represented a drop for the first time in three years, the newly published “Hatch-Waxman ANDA Litigation Report 2017” has said.   2 May 2017
Americas
The US Court of Appeals for the Federal Circuit ruled yesterday that a patent is invalid if the invention was sold before being patented, even if the invention was not publicly disclosed.   2 May 2017
Americas
The US District Court for the District of Delaware has dismissed a dispute between Apotex and Allergan after the companies entered into a settlement agreement.   28 April 2017
Americas
Eli Lilly must pay Germany-based pharmaceutical company Erfindergemeinschaft UroPep $20 million for patent infringement.   25 April 2017
Americas
A disagreement over how pharma patents in Brazil are examined seems to have come to an end, as Breno Souza, Luisa Rezende and Silvia Costa of Clarke Modet & Co Brazil report.   25 April 2017
Americas
Momenta Pharmaceuticals and Sandoz have filed a motion to dismiss competition allegations made by Amphastar Pharmaceuticals.   24 April 2017